Clinical Study of 49 Ankylosing Spondylitis Treated with Integrated Chinese and Western Medicine
Liang Cheng-ming
Abstract
Liang Cheng-ming
Abstract
Objective:To observe the clinical efficacy on ankylosing spondylitis treated with Bushen Huoxue Tongluo Fang(the recipe for kidney tonification,blood activation and meridian circulation promotion)and sulfasalazine tablet. Methods:98 cases of ankylosing spondylitis were randomly divided into treatment group and control group,49 cases in each one. In control group,simply western medicine was applied with sulfasalazine tablet. In treatment group,on the basis of the treatment as control group,Bushen Huoxue Tongluo Fang was supplemented. The clinical efficacy and laboratory indexes [erythrocyte sedimentation rate(ESR)and C-reactive protein(CRP)] were observed. Results:After treatment,the total effective rate was 91.8% in treatment group and was 71.4% in control group,indicating significant difference in comparison(P0.05). After treatment,the outcomes of ESR and CRP of both groups were decreased apparently,indicating significant difference in comparison(P0.05),but the outcomes in treatment group were superior to those in control group. Conclusion:Coordination of Bushen Huoxue Tongluo Fang and sulfasalazine tablet presents significant efficacy on ankylosing spondylitis with less adverse response. This therapy is worth to be promoted in practice.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy on ankylosing spondylitis treated with Bushen Huoxue Tongluo Fang(the recipe for kidney tonification,blood activation and meridian circulation promotion)and sulfasalazine tablet. Methods:98 cases of ankylosing spondylitis were randomly divided into treatment group and control group,49 cases in each one. In control group,simply western medicine was applied with sulfasalazine tablet. In treatment group,on the basis of the treatment as control group,Bushen Huoxue Tongluo Fang was supplemented. The clinical efficacy and laboratory indexes [erythrocyte sedimentation rate(ESR)and C-reactive protein(CRP)] were observed. Results:After treatment,the total effective rate was 91.8% in treatment group and was 71.4% in control group,indicating significant difference in comparison(P0.05). After treatment,the outcomes of ESR and CRP of both groups were decreased apparently,indicating significant difference in comparison(P0.05),but the outcomes in treatment group were superior to those in control group. Conclusion:Coordination of Bushen Huoxue Tongluo Fang and sulfasalazine tablet presents significant efficacy on ankylosing spondylitis with less adverse response. This therapy is worth to be promoted in practice.
Key concepts: Medicine, Ankylosing spondylitis, Sulfasalazine, Erythrocyte sedimentation rate, Western medicine, Internal medicine, Clinical efficacy, Acupuncture